#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sickle cell disease Anal fistula Central nervous system neoplasm Leiomyosarcoma Ependymoma Arginase deficiency Splenic marginal zone lymphoma Non-small cell lung cancer metastatic Alpha-1 antitrypsin deficiency Neonatal alloimmune thrombocytopenia Bladder cancer Anaplastic large cell lymphoma T- and null-cell types Skin angiosarcoma Heritable pulmonary arterial hypertension Short stature More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Treatment Factor VIII deficiency – Life with Disease Behcet’s syndrome – Trials in Disease Combined immunodeficiency – Diagnostics Alternating hemiplegia of childhood – Trials in Disease Richter’s syndrome – Life with Disease Haemophilia A without inhibitors – Diagnostics Choroid melanoma – Diagnostics Fabry’s disease – Basic Information Factor IX deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pertuzumab Lebrikizumab Flortaucipir (18F) CHLORMADINONE ACETATE Bbp-398 Cortisone Cpk850 Human Albumin Solution Anhydrous Cholestyramine Salmeterol Xinafoate Lapatinib Barzolvolimab Nadunolimab Tisagenlecleucel Nifedipine JX10 Dapagliflozin Sulfamethoxazole BROLUCIZUMAB Vorinostat More therapies…

    Learn about Your Condition

    Pemphigus Apathy Infectious pleural effusion Plasma cell myeloma recurrent Hodgkin's disease Ovarian cancer recurrent Gingival bleeding Exfoliation glaucoma Low cardiac output syndrome Marginal zone lymphoma Arterial tortuosity syndrome Small cell lung cancer Renal cancer Primary hypercholesterolaemia Desmoplastic melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. MUDr.Natasa Guklhornova s.r.o.

MUDr.Natasa Guklhornova s.r.o.

Nam. Svabinskeho 956/5, Ceske Budejovice, 370 08, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Meningococcal infection
    Investigated Drugs:
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    • Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    • Neisseria Meningitidis Group W-135 Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    Czechia Denmark Finland Germany Poland Romania

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!